| Literature DB >> 26988376 |
Xiaoxiao Tan1, Xiaojuan Pang1, Mingzhu Lei1, Man Ma1, Fang Guo1, Jinping Wang1, Meng Yu1, Fengping Tan1, Nan Li2.
Abstract
The therapeutic effectiveness of photodynamic therapy (PDT) was hampered by the poor water solubility and instability in physiological conditions of the photosensitizers. Here, we designed folate conjugated thermosensitive liposomes (TSL) as the nanocarrier to improve the solubility, stability and biocompatibility of photosensitizer Chlorin e6 (Ce6). Based on the photothermal effect, we combined copper sulfide (CuS) as the photothermal agent to realize heat-triggered Ce6 release as well as synergistic effect of photothermal and photodynamic therapy. In vitro MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay showed that Ce6-CuS-TSL had low dark toxicity, while performed excellent phototoxicity under the combined 660 and 808 nm laser irradiation compared to any single laser irradiation alone. Moreover, in vivo combination therapy study revealed that Ce6-CuS-TSL inhibited tumor growth to a great extent without evident side effect under the laser irradiation. All detailed evidence demonstrated a considerable potential of Ce6-CuS-TSL for synergistic cancer treatment.Entities:
Keywords: 1,2-Dialmitoyl-sn-glycero-3-phosphocholine (PubChem CID: 452110); 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (PubChem CID: 406952); Chlorin e6; Chlorin e6 (PubChem CID: 5479494); Cholesterol (PubChem CID: 5997); Copper chloride (PubChem CID: 24014); Copper sulfide; Photodynamic therapy; Photothermal therapy; Sodium sulfide hydrate (PubChem CID: 73972); Thermosensitive liposomes
Mesh:
Substances:
Year: 2016 PMID: 26988376 DOI: 10.1016/j.ijpharm.2016.03.019
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875